Interstitial fibrosis in renal grafts: On the way to a better detection;Fibrose interstitielle du greffon rénal : vers un meilleur dépistage

Nephrologie et Therapeutique

Volumn 6, Issue 6, 2010, Pages 494-498

  Cornaire, Émilie ^a   Dubois Xu, Yi Chun ^a   Rondeau, Éric ^a,b   Hertig, Alexandre ^a  

^a HÔPITAL TENON   (France)

^b SORBONNE UNIVERSITÉ   (France)

Author keywords

Interstitial fibrosis; Kidney transplantation; Tubular atrophy; Tubular epithelial cells; Vimentin

Indexed keywords

VIMENTIN;

ATROPHY; CADAVER KIDNEY; CELL DEATH; DISEASE COURSE; EMBRYO DEVELOPMENT; EPITHELIAL MESENCHYMAL TRANSITION; FIBROGENESIS; HUMAN; KIDNEY FIBROSIS; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; KIDNEY TUBULE ATROPHY; KIDNEY TUBULE CELL; KIDNEY TUBULE DISORDER; PROTEIN EXPRESSION; REVIEW;

EID: 78149410570     PISSN: 17697255     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nephro.2010.03.011     Document Type: Short Survey

References (39)

1. H.U. Meier-Kriesche, J.D. Schold, and B. Kaplan Long-term renal allograft survival: have we made significant progress or is it time to rethink our analytic and therapeutic strategies? Am J Transplant 4 8 2004 1289 1295
2. H.U. Meier-Kriesche, J.D. Schold, T.R. Srinivas, and B. Kaplan Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era Am J Transplant 4 3 2004 378 383
3. National Institutes of Health NIoDaDaKD, Bethesda, MD. U.S. Renal Data System, USRDS 2008 Annual Data Report: Atlas of chronic kidney disease and end-stage renal disease in the United States. 2008.
4. H. Ekberg, H. Tedesco-Silva, A. Demirbas, S. Vitko, B. Nashan, and A. Gurkan Reduced exposure to calcineurin inhibitors in renal transplantation N Engl J Med 357 25 2007 2562 2575
5. A. Servais, V. Meas-Yedid, O. Toupance, Y. Lebranchu, A. Thierry, and B. Moulin Interstitial fibrosis quantification in renal transplant recipients randomized to continue cyclosporine or convert to sirolimus Am J Transplant 9 11 2009 2552 2560
6. K. Solez, R.B. Colvin, L.C. Racusen, B. Sis, P.F. Halloran, and P.E. Birk Banff'05 Meeting Report: differential diagnosis of chronic allograft injury and elimination of chronic allograft nephropathy ('CAN') Am J Transplant 7 3 2007 518 526
7. Z.M. El-Zoghby, M.D. Stegall, D.J. Lager, W.K. Kremers, H. Amer, and J.M. Gloor Identifying specific causes of kidney allograft loss Am J Transplant 9 3 2009 527 535
8. B.J. Nankivell, R.J. Borrows, C.L. Fung, P.J. O'Connell, R.D. Allen, and J.R. Chapman The natural history of chronic allograft nephropathy N Engl J Med 349 24 2003 2326 2333
9. F.G. Cosio, J.P. Grande, T.S. Larson, J.M. Gloor, J.A. Velosa, and S.C. Textor Kidney allograft fibrosis and atrophy early after living donor transplantation Am J Transplant 5 5 2005 1130 1136
10. R.S. Gaston Chronic calcineurin inhibitor nephrotoxicity: reflections on an evolving paradigm Clin J Am Soc Nephrol 4 12 2009 2029 2034
11. B.M. McGuire, B.A. Julian, J.S. Bynon Jr., W.J. Cook, S.J. King, and J.J. Curtis Brief communication: Glomerulonephritis in patients with hepatitis C cirrhosis undergoing liver transplantation Ann Intern Med 144 10 2006 735 741
12. F. Gonzalez-Vilchez, J.A. de Prada, V. Exposito, T. Garcia-Camarero, L. Fernandez-Friera, and M. Llano Avoidance of calcineurin inhibitors with use of proliferation signal inhibitors in de novo heart transplantation with renal failure J Heart Lung Transplant 27 10 2008 1135 1141
13. F. Vincenti, C. Larsen, A. Durrbach, T. Wekerle, B. Nashan, and G. Blancho Costimulation blockade with belatacept in renal transplantation N Engl J Med 353 8 2005 770 781
14. M. Hazzan, M. Labalette, M.C. Copin, F. Glowacki, F. Provot, and F.R. Pruv Predictive factors of acute rejection after early cyclosporine withdrawal in renal transplant recipients who receive mycophenolate mofetil: results from a prospective, randomized trial J Am Soc Nephrol 16 8 2005 2509 2516
15. G. Opelz, M. Zeier, G. Laux, C. Morath, and B. Dohler No improvement of patient or graft survival in transplant recipients treated with angiotensin-converting enzyme inhibitors or angiotensin II type 1 receptor blockers: a collaborative transplant study report J Am Soc Nephrol 17 11 2006 3257 3262
16. E.G. Neilson Plasticity, nuclear diapause, and a requiem for the terminal differentiation of epithelia J Am Soc Nephrol 18 7 2007 1995 1998
17. R. Kalluri, and R.A. Weinberg The basics of epithelial-mesenchymal transition J Clin Invest 119 6 2009 1420 1428
18. Y. Liu Epithelial to mesenchymal transition in renal fibrogenesis: pathologic significance, molecular mechanism, and therapeutic intervention J Am Soc Nephrol 15 1 2004 1 12
19. H. Acloque, M.S. Adams, K. Fishwick, M. Bronner-Fraser, and M.A. Nieto Epithelial-mesenchymal transitions: the importance of changing cell state in development and disease J Clin Invest 119 6 2009 1438 1449
20. F. Strutz, H. Okada, C.W. Lo, T. Danoff, R.L. Carone, and J.E. Tomaszewski Identification and characterization of a fibroblast marker: FSP1 J Cell Biol 130 2 1995 393 405
21. M. Iwano, D. Plieth, T.M. Danoff, C. Xue, H. Okada, and E.G. Neilson Evidence that fibroblasts derive from epithelium during tissue fibrosis J Clin Invest 110 3 2002 341 350
22. R. Kalluri EMT: when epithelial cells decide to become mesenchymal-like cells J Clin Invest 119 6 2009 1417 1419
23. R. Kalluri, and E.G. Neilson Epithelial-mesenchymal transition and its implications for fibrosis J Clin Invest 112 12 2003 1776 1784
24. Y. Teng, M. Zeisberg, and R. Kalluri Transcriptional regulation of epithelial-mesenchymal transition J Clin Invest 117 2 2007 304 306
25. M. Mengel, J. Reeve, S. Bunnag, G. Einecke, B. Sis, and T. Mueller Molecular correlates of scarring in kidney transplants: the emergence of mast cell transcripts Am J Transplant 9 1 2009 169 178
26. A. Scherer, W. Gwinner, M. Mengel, T. Kirsch, F. Raulf, and J.D. Szustakowski Transcriptome changes in renal allograft protocol biopsies at 3 months precede the onset of interstitial fibrosis/tubular atrophy (IF/TA) at 6 months Nephrol Dial Transplant 24 8 2009 2567 2575
27. S. Rodder, A. Scherer, F. Raulf, C.C. Berthier, A. Hertig, and L. Couzi Renal allografts with IF/TA display distinct expression profiles of metzincins and related genes Am J Transplant 9 3 2009 517 526
28. M. Muramatsu, M. Miyagi, Y. Ishikawa, A. Aikawa, S. Mizuiri, and T. Ohara Estimation of damaged tubular epithelium in renal allografts by determination of vimentin expression Int J Urol 11 11 2004 954 962
29. A. Vongwiwatana, A. Tasanarong, D.C. Rayner, A. Melk, and P.F. Halloran Epithelial to mesenchymal transition during late deterioration of human kidney transplants: the role of tubular cells in fibrogenesis Am J Transplant 5 6 2005 1367 1374
30. A. Hertig, J. Verine, B. Mougenot, C. Jouanneau, N. Ouali, and P. Sebe Risk factors for early epithelial to mesenchymal transition in renal grafts Am J Transplant 6 12 2006 2937 2946
31. A. Hertig, D. Anglicheau, J. Verine, N. Pallet, M. Touzot, and P.Y. Ancel Early epithelial phenotypic changes predict graft fibrosis J Am Soc Nephrol 19 8 2008 1584 1591
32. M.J. Vitalone, P.J. O'Connell, E. Jimenez-Vera, A. Yuksel, M. Wavamunno, and C.L. Fung Epithelial-to-mesenchymal transition in early transplant tubulointerstitial damage J Am Soc Nephrol 19 8 2008 1571 1583
33. D.F. Higgins, K. Kimura, W.M. Bernhardt, N. Shrimanker, Y. Akai, and B. Hohenstein Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition J Clin Invest 117 12 2007 3810 3820
34. H. Robertson, S. Ali, B.J. McDonnell, A.D. Burt, and J.A. Kirby Chronic renal allograft dysfunction: the role of T cell-mediated tubular epithelial to mesenchymal cell transition J Am Soc Nephrol 15 2 2004 390 397
35. N. Pallet, N. Bouvier, A. Bendjallabah, M. Rabant, J.P. Flinois, and A. Hertig Cyclosporine-induced endoplasmic reticulum stress triggers tubular phenotypic changes and death Am J Transplant 8 11 2008 2283 2296
36. E.M. Zeisberg, S.E. Potenta, H. Sugimoto, M. Zeisberg, and R. Kalluri Fibroblasts in kidney fibrosis emerge via endothelial-to-mesenchymal transition J Am Soc Nephrol 19 12 2008 2282 2287
37. M. Zeisberg, J. Hanai, H. Sugimoto, T. Mammoto, D. Charytan, and F. Strutz BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury Nat Med 9 7 2003 964 968
38. H. Sugimoto, G. Grahovac, M. Zeisberg, and R. Kalluri Renal fibrosis and glomerulosclerosis in a new mouse model of diabetic nephropathy and its regression by bone morphogenic protein-7 and advanced glycation end product inhibitors Diabetes 56 7 2007 1825 1833
39. M. Zeisberg, C. Yang, M. Martino, M.B. Duncan, F. Rieder, and H. Tanjore Fibroblasts derive from hepatocytes in liver fibrosis via epithelial to mesenchymal transition J Biol Chem 282 32 2007 23337 23347